Citigroup Cuts Teladoc Health (NYSE:TDOC) Price Target to $9.00

Teladoc Health (NYSE:TDOC) had its price objective lowered by analysts at Citigroup from $10.00 to $9.00 in a research note issued on Friday,Benzinga reports. The brokerage presently has a “neutral” rating on the health services provider’s stock. Citigroup’s target price would indicate a potential upside of 20.56% from the company’s current price.

A number of other research analysts have also weighed in on the stock. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Bank of America dropped their price objective on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. Zacks Research downgraded Teladoc Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 10th. Evercore ISI dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research report on Thursday, October 30th. Finally, Barclays initiated coverage on shares of Teladoc Health in a research report on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 price target on the stock. Five investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $9.50.

Teladoc Health Stock Down 1.9%

Shares of TDOC traded down $0.15 during mid-day trading on Friday, hitting $7.47. 888,147 shares of the company’s stock were exchanged, compared to its average volume of 4,598,998. The stock has a market cap of $1.32 billion, a price-to-earnings ratio of -5.83 and a beta of 2.04. Teladoc Health has a twelve month low of $6.35 and a twelve month high of $15.21. The firm has a fifty day moving average of $7.40 and a two-hundred day moving average of $7.81. The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The firm had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. During the same quarter in the prior year, the business earned ($0.19) earnings per share. The company’s revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, sell-side analysts forecast that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Buying and Selling

In other news, insider Fernando M. Rodrigues sold 4,209 shares of the company’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total value of $31,483.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Carlos Nueno sold 3,897 shares of the business’s stock in a transaction on Tuesday, December 2nd. The shares were sold at an average price of $7.49, for a total value of $29,188.53. Following the completion of the sale, the insider directly owned 27,175 shares in the company, valued at approximately $203,540.75. This represents a 12.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 33,288 shares of company stock valued at $251,684 over the last ninety days. Company insiders own 0.58% of the company’s stock.

Institutional Trading of Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Teacher Retirement System of Texas lifted its stake in shares of Teladoc Health by 5.7% in the 2nd quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider’s stock valued at $232,000 after purchasing an additional 1,431 shares during the period. Federated Hermes Inc. increased its holdings in Teladoc Health by 0.5% in the third quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider’s stock valued at $2,379,000 after purchasing an additional 1,450 shares during the last quarter. Creative Planning lifted its stake in Teladoc Health by 7.7% in the third quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock valued at $159,000 after buying an additional 1,462 shares during the period. Krane Funds Advisors LLC boosted its holdings in Teladoc Health by 13.4% during the third quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider’s stock worth $106,000 after buying an additional 1,469 shares during the last quarter. Finally, State of Wyoming boosted its holdings in Teladoc Health by 2.1% during the third quarter. State of Wyoming now owns 79,075 shares of the health services provider’s stock worth $611,000 after buying an additional 1,628 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.